InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Hexter Joshua, Chief Executive Officer. Officer active across 1 company, notably Oramed Pharmaceuticals INC.. Aggregated, 12 disclosures have been logged. Activity tracked since 11 February 2025. The latest transaction was filed on 17 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hexter Joshua
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
95,889 shares0Common StockSEC:0001213900-26-031012:0
19,000 shares0Common StockSEC:0001213900-26-009477:0
97,328 shares0Common StockSEC:0001213900-26-001278:0
45,000 shares0Common StockSEC:0001213900-25-012240:0
194,500 sharesCommon StockSEC:0001213900-25-001165:0
30,000 sharesCommon StockSEC:0001213900-24-095929:0
180,500 sharesCommon StockSEC:0001209191-24-001148:0
27,000 sharesCommon StockSEC:0001209191-23-033142:0
108,000 sharesCommon StockSEC:0001209191-23-024940:0
42,000 sharesCommon StockSEC:0001209191-22-043767:0
21,000 sharesCommon StockSEC:0001213900-22-000807:0
33,333 sharesCommon StockSEC:0001213900-21-046410:0
12 of 12 declarations
About Hexter Joshua
Hexter Joshua is Chief Executive Officer and Commercial Director. He is associated with Oramed Pharmaceuticals INC. (XNAS) as COO & CBO. The declarant has 12 filings in total, and across the 12 sampled filings the most frequent transaction nature is Award, with publications from 2021-09-02 to 2026-03-18.
